Trials / Completed
CompletedNCT05866276
To Determine the Accuracy of SCreening for Occult REnal Disease (SCORED) Questionnaire for CKD Risk Among Asian Patients
A Real-World Multicentre Prospective Study to Determine the Accuracy of the SCORED (SCreening for Occult REnal Disease) Questionnaire for SCreening REnal Risk Early Against Nephropathy in Adult Population in Asia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,426 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To determine the accuracy of SCreening for Occult REnal Disease (SCORED) questionnaire for CKD risk among Asian Patients
Conditions
Timeline
- Start date
- 2023-06-22
- Primary completion
- 2024-05-31
- Completion
- 2024-05-31
- First posted
- 2023-05-19
- Last updated
- 2025-03-20
Locations
3 sites across 2 countries: Indonesia, Vietnam
Source: ClinicalTrials.gov record NCT05866276. Inclusion in this directory is not an endorsement.